Adverse events64

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 64

Type	Event	Organ system	Group	Affected	At risk
other	Diarrhea	Gastrointestinal disorders	1st Intervention Period:SLx-4090 Placebo/Orlistat Placebo	0	2
other	Diarrhea	Gastrointestinal disorders	1st Intervention Period:Orlistat/Placebo	0	1
other	Diarrhea	Gastrointestinal disorders	1st Intervention Period:Orlistat Placebo /Slx-4090	1	1
other	Diarrhea	Gastrointestinal disorders	1st Intervention Period:Orlistat/SLx-4090	1	1
other	Diarrhea	Gastrointestinal disorders	2nd Intervention Period:SLx-4090 Placebo/Orlistat Placebo	0	1
other	Diarrhea	Gastrointestinal disorders	2nd Intervention Period:Orlistat/Placebo	0	1
other	Diarrhea	Gastrointestinal disorders	2nd Intervention Period:Orlistat Placebo /Slx-4090	0	1
other	Diarrhea	Gastrointestinal disorders	2nd Intervention Period:Orlistat/SLx-4090	0	2
other	Diarrhea	Gastrointestinal disorders	3rd Intervention Period:SLx-4090 Placebo/Orlistat Placebo	0	1
other	Diarrhea	Gastrointestinal disorders	3rd Intervention Period:Orlistat/Placebo	0	1
other	Diarrhea	Gastrointestinal disorders	3rd Intervention Period:Orlistat Placebo /Slx-4090	0	1
other	Diarrhea	Gastrointestinal disorders	3rd Intervention Period:Orlistat/SLx-4090	0	0
other	Diarrhea	Gastrointestinal disorders	4th Intervention Period:SLx-4090 Placebo/Orlistat Placebo	0	1
other	Diarrhea	Gastrointestinal disorders	4th Intervention Period:Orlistat/Placebo	0	0
other	Diarrhea	Gastrointestinal disorders	4th Intervention Period:Orlistat Placebo /Slx-4090	0	1
other	Diarrhea	Gastrointestinal disorders	4th Intervention Period:Orlistat/SLx-4090	0	0
other	Abdominal pain	Gastrointestinal disorders	1st Intervention Period:SLx-4090 Placebo/Orlistat Placebo	0	2
other	Abdominal pain	Gastrointestinal disorders	1st Intervention Period:Orlistat/Placebo	0	1
other	Abdominal pain	Gastrointestinal disorders	1st Intervention Period:Orlistat Placebo /Slx-4090	0	1
other	Abdominal pain	Gastrointestinal disorders	1st Intervention Period:Orlistat/SLx-4090	0	1

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01675154/events

API reference For AI assistants

Adverse events64

Sources 3

Read this list from software.